Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...
Companies with high reputational strength recorded unexpected shareholder gains, while gaps in workplace practices signal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback